# Real World COVID-19 Antiviral Effectiveness Research

> **NCT05638919** · — · UNKNOWN · sponsor: **Clinical Research Centre, Malaysia** · enrollment: 660 (estimated)

## Conditions studied

- COVID-19

## Interventions

- **DRUG:** Oral Antiviral

## Key facts

- **NCT ID:** NCT05638919
- **Lead sponsor:** Clinical Research Centre, Malaysia
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-12-06
- **Primary completion:** 2023-07-30
- **Final completion:** 2023-07-31
- **Target enrollment:** 660 (ESTIMATED)
- **Last updated:** 2023-05-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05638919

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05638919, "Real World COVID-19 Antiviral Effectiveness Research". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05638919. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*